A relative increase in circulating platelets following chemoradiation predicts for poor survival of patients with glioblastoma

BACKGROUND: Thrombocytosis is triggered by and promotes tumor growth. The relationship between the change in circulating platelets after chemoradiation therapy (CRT) or adjuvant temozolomide (TMZ) and survival in glioblastoma remains unclear. We hypothesized that an increase in platelets after these...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonyawan, Keeratikarn, Hess, Kenneth R., Yang, Jie, Long, Lihong, Wang, Qianghu, Ezhilarasan, Ravesanker, Auia, Alessandra, Alfaro-Munoz, Kristin D., de Groot, John F., Bhat, Krishna P., Sulman, Erik P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685768/
https://www.ncbi.nlm.nih.gov/pubmed/29163847
http://dx.doi.org/10.18632/oncotarget.21799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685768/
https://www.ncbi.nlm.nih.gov/pubmed/29163847
http://dx.doi.org/10.18632/oncotarget.21799

Ejemplares similares